Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Liabilities and Shareholders Equity: 2019-2024

Historic Liabilities and Shareholders Equity for CureVac N.V (CVAC) over the last 6 years, with Dec 2024 value amounting to $857.9 million.

  • CureVac N.V's Liabilities and Shareholders Equity rose 30.04% to $779.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.4 billion, marking a year-over-year increase of 7.75%. This contributed to the annual value of $857.9 million for FY2024, which is 1.15% up from last year.
  • According to the latest figures from FY2024, CureVac N.V's Liabilities and Shareholders Equity is $857.9 million, which was up 1.15% from $848.1 million recorded in FY2023.
  • Over the past 5 years, CureVac N.V's Liabilities and Shareholders Equity peaked at $1.8 billion during FY2020, and registered a low of $848.1 million during FY2023.
  • Moreover, its 3-year median value for Liabilities and Shareholders Equity was $857.9 million (2024), whereas its average is $861.3 million.
  • Per our database at Business Quant, CureVac N.V's Liabilities and Shareholders Equity soared by 1,146.34% in 2020 and then crashed by 33.74% in 2022.
  • CureVac N.V's Liabilities and Shareholders Equity (Yearly) stood at $1.8 billion in 2020, then decreased by 26.47% to $1.3 billion in 2021, then tumbled by 33.74% to $877.9 million in 2022, then decreased by 3.39% to $848.1 million in 2023, then grew by 1.15% to $857.9 million in 2024.